Back to CA Clearstead Advisors, LLC
ALXO
2 quarters
Position history for CAClearstead Advisors, LLC's holdings in ALX Oncology Holdings Inc.
No. Clearstead Advisors exited its ALXO (ALX Oncology Holdings) position in Q3 2025. Its Q2 2025 13F listed 177 shares worth $74. Clearstead Advisors first reported ALXO in Q2 2025 and held it in 1 quarterly 13F filing.
Final Value
$0
Final Shares
0
Total Value Change
-$74
Total Shares Change
-177
Quarter-by-Quarter History